BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hematopoietic cell
,
Lipopolysaccharide
,
rs6983267
,
SIRT1
,
Angiogenesis
,
Arthritis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
vascular endothelial growth factor receptor- 2
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
4-aminopyrimidine-5-carbaldehyde oximes as potent VEGFR-2 inhibitors. Part II.
The observed correlation between in vivo clinical pharmacokinetic parameters and in vitro potency of…
Regulation of soluble VEGFR-2 secreted by microvascular endothelial cells derived from human BPH.
Activation of VEGFR-2 signaling in response to moderate dose of ultraviolet B promotes survival of n…
The mechanisms of cerebral vascular dysfunction and neuroinflammation by MMP-mediated degradation of…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Soluble Vascular Endothelial Growth Factor Receptor 2 as Predictor of Benefit From Bevacizumab Beyon…
A Study of HLX06, a Humanized Monoclonal Antibody Targeting Human Vascular Endothelial Growth Factor…
Evaluation of Reporting of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor…
Proteomics and Stem Cell Therapy as a New Vascularization Strategy
A Study of Second-line Treatment With Apatinib in Patients With Advanced Intrahepatic Cholangiocarci…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ